PIRAMAL ENTERPRISES LTD.

NSE : PELBSE : 500302ISIN CODE : INE140A01024Industry : Pharmaceuticals & DrugsHouse : Piramal Ajay
BSE2252.6058.35 (+2.66 %)
PREV CLOSE ( ) 2194.25
OPEN PRICE ( ) 2204.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 150546
TODAY'S LOW / HIGH ( )2179.70 2330.45
52 WK LOW / HIGH ( )990 2330.45
NSE2252.8056.85 (+2.59 %)
PREV CLOSE( ) 2195.95
OPEN PRICE ( ) 2188.00
BID PRICE (QTY) 2252.80 (6)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3401862
TODAY'S LOW / HIGH( ) 2180.95 2331.00
52 WK LOW / HIGH ( )990 2331
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 26-04 1947
Management Info
Ajay Piramal - Chairman - Managing Director
Registered Office

Address Piramal Ananta Agastya Corporate Park ,Opposite Fire Brigade , Kamani Junction , L B S Marg ,Kurla ( W ),
Mumbai,
Maharashtra-400070

Phone 022 3802 3000/4000

Email complianceofficer.phl@piramal.com

Website www.piramal.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
11Jun Piramal Enterprises informs about paym
In compliance with Regulation 57 of the Listing Regulations, Piramal Ent..
09Jun Piramal Enterprises’ arm, NITI Aayog l
Piramal Enterprises’ philanthropic arm -- Piramal Foundation along with..
19May Piramal Enterprises informs about anal
Piramal Enterprises has informed that pursuant to Regulation 30(6) of th..
14May Piramal Enterprises reports consolidat
Piramal Enterprises has reported results for fourth quarter and year end..
14May Piramal Enterprises falls after report
Piramal Enterprises is currently trading at Rs. 1646.35, down by 48.25 p..
Financials
Rs. in Millions
QTR Mar 21 ANNUAL 21
Net Profit787.1398.999999999997
Gross Profit 1292.2 -692.000000000003
Operating Profit 3175.412907.4
Net Sales 4935.918247
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 16323.30 (1.37%)
M.Cap (Rs. in Cr)34685.87
Dr. Reddys Lab (BSE)
 5451.20 (3.03%)
M.Cap (Rs. in Cr)90677.61
Alkem Laboratories (BSE)
 3195.75 (2.11%)
M.Cap (Rs. in Cr)38209.98
Caplin Point Lab (BSE)
 663.80 (7.98%)
M.Cap (Rs. in Cr)5021.17
Aurobindo Pharma (BSE)
 1010.25 (4.70%)
M.Cap (Rs. in Cr)59194.45
Shareholding Pattern
PROMOTERS 46.06%
NON-INSTITUTION 14.33%
FI/BANKS/INSURANCE 8.78%
MUTUAL FUNDS/UTI 1.4%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075,9768009000, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.